微型简单角膜缘上皮移植与结膜角膜缘自体移植治疗原发性翼状胬肉:随机对照试验研究方案
本研究为随机对照试验,计划纳入68例原发性翼状胬肉患者,随机均分为两组,分别接受结膜角膜缘自体移植(CLAu)或改良微型简单角膜缘上皮移植(mini-SLET),术后随访12个月,比较复发率。研究旨在通过改良mini-SLET技术提高角膜干细胞活性并减少复发,为患者提供更有效、微创的替代金标准手术的方案。
要点
- 68例原发性翼状胬肉患者随机均分为CLAu组和mini-SLET组。
- 主要比较两组术后12个月内的复发率。
- mini-SLET为改良技术,旨在提高角膜干细胞活性并减少复发。
核心结论
- 本研究通过改良mini-SLET技术以提高角膜干细胞活性并减少复发,旨在为患者提供比金标准手术更有效且微创的替代方案。
研究设计与样本
- I组行翼状胬肉切除联合结膜角膜缘自体移植(CLAu),II组行翼状胬肉切除联合微型简单角膜缘上皮移植(mini-SLET)。
- 采用密封信封法确保分配隐藏,手术由两名外科医生完成,术后定期随访至12个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pterygium is a wing-shaped fibrovascular growth over the cornea that may require surgical removal due to recurrence and cosmetic concerns. This randomized controlled trial compares the recurrence rate of conjunctival-limbal autograft (CLAu) with a modified mini-simple limbal epithelial transplant (mini-SLET) technique. METHODS: 68 patients will be randomly assigned to two equally sized groups via simple randomization. Group I will undergo a pterygium excision with CLAu, while Group II will undergo a pterygium excision using a mini-SLET. Allocation concealment will be ensured using sealed envelopes, and procedures will be performed by two surgeons. Patients will be followed postoperatively at regular intervals for up to 12 months. DISCUSSION: This study builds on previous research by modifying the mini-SLET technique to enhance corneal stem cell viability and reduce recurrence. By refining this method, we aim to offer patients a more effective and minimally invasive alternative to the gold-standard procedure. TRIAL REGISTRATION: ClinicalTrials.gov, NCT06402643. Registered on April 15, 2024.
引用
- Vera-Duarte GR, Ortiz-Morales G, Müller-Morales CA, et al. Mini-simple limbal epithelial transplantation and conjunctival-limbal autograft for the treatment of primary pterygium: Study protocol for a randomized controlled trial. Trials. 2025. PMID: 41174752. doi:10.1186/s13063-025-09075-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。